Aldehyde dehydrogenase 3A1 associates with prostate tumorigenesis

Por Yan, J, De Melo, J, Cutz, J-C, Aziz, T, Tang, D
Publicado em 2014

Diagnosing lung cancer in the 21st century: are we ready to meet the challenge of individualized care?

Por VanderMeer, R., Chambers, S., Van Dam, A., Cutz, J.C., Goffin, J.R., Ellis, P.M.
Publicado no Curr Oncol (2015)

Amplification of telomerase (hTERT) gene is a poor prognostic marker in non-small-cell lung cancer

Por Zhu, C-Q, Cutz, J-C, Liu, N, Lau, D, Shepherd, F A, Squire, J A, Tsao, M-S
Publicado em 2006

Metformin inhibits growth and enhances radiation response of non-small cell lung cancer (NSCLC) through ATM and AMPK

Por Storozhuk, Y, Hopmans, S N, Sanli, T, Barron, C, Tsiani, E, Cutz, J-C, Pond, G, Wright, J, Singh, G, Tsakiridis, T
Publicado em 2013

Improving molecular testing and personalized medicine in non-small-cell lung cancer in Ontario

Por Lim, C., Sekhon, H.S., Cutz, J.C., Hwang, D.M., Kamel-Reid, S., Carter, R.F., Santos, G. da Cunha, Waddell, T., Binnie, M., Patel, M., Paul, N., Chung, T., Brade, A., El-Maraghi, R., Sit, C., Tsao, M.S., Leighl, N.B.
Publicado no Curr Oncol (2017)